Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis

BACKGROUND: Symptomatic slow-acting drugs for osteoarthritis (SYSADOAs) are an important drug class in the treatment armamentarium for osteoarthritis (OA). OBJECTIVE: We aimed to re-assess the safety of various SYSADOAs in a comprehensive meta-analysis of randomized placebo-controlled trials, using,...

Descripción completa

Detalles Bibliográficos
Autores principales: Honvo, Germain, Reginster, Jean-Yves, Rabenda, Véronique, Geerinck, Anton, Mkinsi, Ouafa, Charles, Alexia, Rizzoli, Rene, Cooper, Cyrus, Avouac, Bernard, Bruyère, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509099/
https://www.ncbi.nlm.nih.gov/pubmed/31073924
http://dx.doi.org/10.1007/s40266-019-00662-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509099/
https://www.ncbi.nlm.nih.gov/pubmed/31073924
http://dx.doi.org/10.1007/s40266-019-00662-z

Ejemplares similares